首页> 外文期刊>Transplantation Proceedings >Combination treatment with donor interleukin-12p35 silenced dendritic cells and cyclosporine induces long-term survival of intestinal allografts in rats.
【24h】

Combination treatment with donor interleukin-12p35 silenced dendritic cells and cyclosporine induces long-term survival of intestinal allografts in rats.

机译:供体白细胞介素12p35沉默树突状细胞和环孢素的联合治疗可诱导大鼠同种异体肠的长期存活。

获取原文
获取原文并翻译 | 示例
           

摘要

Immune tolerance promises to enhance allograft survival while reducing risks inherent to immunosuppressants. In this study, we evaluated the effect of interleukin (IL)-12p35 silenced dendritic cells (DC) combined with cyclosporine (CsA) on induction of immune tolerance in intestinal transplantation. The results showed that combination treatment with donor IL-12p35 silenced DC and a low dose of CsA (8 mg/kg) prolonged rat intestinal allograft survival. However, a higher dose of CsA (20 mg/kg) did not further prolong allograft survival.
机译:免疫耐受有望提高同种异体移植的存活率,同时降低免疫抑制剂固有的风险。在这项研究中,我们评估了白介素(IL)-12p35沉默树突状细胞(DC)联合环孢素(CsA)对肠移植中免疫耐受诱导的影响。结果表明,用供体IL-12p35联合治疗可使DC沉默和低剂量的CsA(8 mg / kg)延长大鼠肠移植的存活时间。但是,较高剂量的CsA(20 mg / kg)不能进一步延长同种异体移植的存活时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号